What is Ginkgo Bioworks's pre-tax income?

Ginkgo Bioworks (DNA) reported pre-tax income of -$76.14M in Q1 2026.

How has Ginkgo Bioworks's pre-tax income changed year-over-year?

Ginkgo Bioworks's pre-tax income increased by 8.5% year-over-year, from -$83.22M to -$76.14M.

What is the long-term trend for Ginkgo Bioworks's pre-tax income?

Over 4 years (2021 to 2025), Ginkgo Bioworks's pre-tax income has grown at a -36.1% compound annual growth rate (CAGR), from -$1.84B to -$305.95M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ginkgo Bioworks DNA Pre-Tax Income

Pre-Tax Income at other companies

Thermo Fisher ScientificTMO

$1.73B+7.0%

AbCellera Biologics Inc.ABCL

-$49.54M+6.5%

TEC

Bio-TechneTECH

$71.23M+86.1%

AzentaAZTA

-$157.34M-1,154%

Maravai LifeSciences Holdings, Inc.MRVI

-$6.53M+87.6%

Bio-Rad LaboratoriesBIO

-$689.8M-927%

Segments

By segment

See full

Reportable Segment-$76.14M+8.5%

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's pre-tax income?: Ginkgo Bioworks (DNA) reported pre-tax income of -$76.14M in Q1 2026.
How has Ginkgo Bioworks's pre-tax income changed year-over-year?: Ginkgo Bioworks's pre-tax income increased by 8.5% year-over-year, from -$83.22M to -$76.14M.
What is the long-term trend for Ginkgo Bioworks's pre-tax income?: Over 4 years (2021 to 2025), Ginkgo Bioworks's pre-tax income has grown at a -36.1% compound annual growth rate (CAGR), from -$1.84B to -$305.95M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.